MikroScore
Science-backed ingredient evidence
Moderate Evidence Safety: Use with caution Study dose: 100 mg/day

Vitamin E (Tocopherole)

Also known as: Tocopherol, Alpha-Tocopherol, Gamma-Tocopherol, Tocotrienole, d-alpha-Tocopherol

Summary Moderate Evidence

Vitamin E: 8 lipid-soluble antioxidants protecting cell membranes. Natural mixed tocopherols are generally safe; high-dose synthetic forms carry risks documented in the SELECT trial.

EU Health Claims: Approved

EFSA has approved health claims for Vitamin E: protection of cells against oxidative stress. Daily requirement: 13 mg (men), 11 mg (women). Upper tolerable intake: 300 mg/day. EFSA does not distinguish between synthetic and natural forms in claims, but bioavailability differs significantly.

AI Summary

Quick verdict

Vitamin E: 8 lipid-soluble antioxidants protecting cell membranes. Natural mixed tocopherols are generally safe; high-dose synthetic forms carry risks documented in the SELECT trial.

What the evidence supports

Essential antioxidant function and EFSA-approved claims are well-documented. High-dose supplementation (400+ IU) showed increased prostate cancer risk in SELECT trial.

What is NOT supported

Long-term safety and rare adverse effects in humans remain insufficiently studied.

EU/EFSA status

Approved. EFSA has approved health claims for Vitamin E: protection of cells against oxidative stress. Dail…

Safety

Use with caution

This AI summary is generated from the structured data on this page.

What is Vitamin E?

“Vitamin E” is not a single compound, but rather a family of 8 related molecules: 4 tocopherols (alpha, beta, gamma, delta) and 4 tocotrienols (alpha, beta, gamma, delta). All are lipid-soluble antioxidants that protect cell membranes from lipid peroxidation—essentially shielding the polyunsaturated fatty acids in cell membranes from damage by oxygen radicals. This protective function is biologically essential and explains the EFSA-approved health claim for cellular protection against oxidative stress.

The body has complex mechanisms to handle the different forms of vitamin E. Alpha-tocopherol is preferentially retained by the liver due to its high affinity for the alpha-tocopherol transfer protein (α-TTP), which is why blood levels of alpha-tocopherol are used as a biomarker. However, this selective retention means that high supplementation with alpha-tocopherol can displace other tocopherols—especially gamma-tocopherol—from the body, potentially eliminating their benefits.

Natural vs. Synthetic: A Critical Distinction

FormExamplesSafety Profile
Synthetic dl-Alpha-TocopherolMost budget supplementsSELECT trial: increased prostate cancer risk
Natural d-Alpha-TocopherolPremium supplementsBetter bioavailable, fewer risk data
Mixed TocopherolsNature-identical blendsSuperior profile to isolated alpha
TocotrienolsPalm oil, annattoPotentially superior for healthy ageing

The fundamental problem: most vitamin E supplements contain synthetic dl-alpha-tocopherol. This synthetic form is a racemic mixture—50% is the biologically active d-form, and 50% is the inactive l-form that your body simply discards. This means you’re buying an expensive supplement where half is wasted.

Furthermore, high-dose alpha-tocopherol supplementation actively depletes gamma-tocopherol and other tocopherols from your body. Gamma-tocopherol, in particular, has distinct biological properties not shared with alpha-tocopherol, including anti-inflammatory and chemopreventive mechanisms. By taking high-dose alpha-tocopherol supplements, you may inadvertently reduce net antioxidant function—a counterintuitive and underappreciated problem.

The SELECT Trial: A Major Safety Signal

The SELECT trial (Selenium and Vitamin E Cancer Prevention Trial) is one of the most important negative supplement studies ever conducted. Published in 2011, it followed 35,533 healthy men aged 50+ over 5+ years. Half received 400 IU of synthetic vitamin E daily; half received placebo.

The result: 17% increased prostate cancer risk in the vitamin E group—a statistically significant finding that led to early termination of that arm of the study. The trial was carefully designed, well-powered, and conducted in a modern health-care setting. This is not a small pilot study or a questionable meta-analysis; this is robust evidence of harm.

Importantly, the SELECT signal applies specifically to high-dose (400 IU+), synthetic alpha-tocopherol taken as a standalone supplement. Whether natural mixed tocopherols carry the same risk is unproven and unlikely, but the distinction matters enormously for supplement selection.

Additional Safety Concerns

A 2005 meta-analysis by Miller and colleagues found that vitamin E supplementation at doses above 400 IU daily was associated with a small but consistent elevation in all-cause mortality. The pooled analysis suggested approximately 1 additional death per 1,000 people per year at high doses. While methodologically debated (heterogeneity among trials, publication bias concerns), this finding corroborates the SELECT signal and reinforces caution.

Interaction with blood thinners: Vitamin E has mild anticoagulant properties. If you take warfarin, clopidogrel, or aspirin at therapeutic doses, high-dose vitamin E supplementation could potentiate bleeding risk. Discuss with your physician if you’re taking both.

What the Evidence Actually Supports

Clearly Established (EFSA-Approved)

  • Cellular protection against oxidative stress: This is well-documented and the basis for the approved health claim. Adequate vitamin E intake is genuinely important for this function.

Unproven or Negative for High-Dose Supplementation

  • Cardiovascular protection: Major RCTs (HOPE, GISSI) found no meaningful benefit of high-dose vitamin E on heart disease or stroke
  • Cancer prevention (except prostate): Large trials found no protective benefit; SELECT found increased prostate cancer risk
  • Cognitive decline or dementia: Some observational data, but no convincing RCT evidence
  • Longevity or healthy ageing: Despite theoretical appeal, unproven in humans

Promising but Early-Stage Evidence (Tocotrienols)

  • Neuroprotection: Preclinical evidence for stroke and neurodegenerative disease
  • Anticarcinogenic properties: Interesting mechanisms in cell culture and animal models, but human data scarce
  • Cardiovascular markers: Some data on lipid improvement and arterial flexibility

Food vs. Supplements

Daily vitamin E requirements (11–13 mg) are straightforward to meet through food. Excellent sources include walnuts, almonds, sunflower oil, wheat germ oil, avocado, and leafy greens. A small handful of almonds or a tablespoon of sunflower oil covers a full day’s need.

For well-nourished individuals, vitamin E supplementation is not necessary and carries documented risks at high doses. The exception might be mixed tocopherols or tocotrienols at modest doses (20–50 mg daily) as a longevity strategy, but the evidence is speculative.

Safety Assessment

  • Food-based amounts: Safe
  • 15–100 mg daily from natural mixed tocopherols: Likely safe
  • >400 IU daily of synthetic alpha-tocopherol: Caution—SELECT trial signal, not recommended
  • With anticoagulant medications: Discuss with your doctor; may increase bleeding risk

Vitamin E is a textbook case where biochemical plausibility (antioxidation) does not translate to human benefit, and where high-dose supplementation paradoxically increases harm. Ensure adequate intake through diet; supplement cautiously if at all.

Key Studies

Selenium for preventing cancer

Vinceti et al. (2018)

RCT (n=35,533): 400 IU synthetic vitamin E/day was significantly associated with 17% increased prostate cancer risk. Trial stopped early. Most important vitamin E safety signal in recent decades.

PubMed PMID 29376219

Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality

Miller ER et al. (2005)

Meta-analysis: High-dose vitamin E (>400 IU/day) associated with slightly elevated all-cause mortality. Methodologically contested, but an important signal warranting caution.

PubMed PMID 15537682

Tocotrienols: the emerging face of natural vitamin E

Sen et al. (2007)

Review: Tocotrienols (especially delta- and gamma-forms) demonstrate preclinically interesting neuroprotective, anticarcinogenic and cardioprotective effects absent in alpha-tocopherol. Potentially superior candidates for healthy ageing.

PubMed PMID 17628176
Editorial notice: For most ingredients described here, no health claims are approved in the EU (Regulation (EC) 1924/2006). Evidence levels are editorial assessments of research quality — not health promises. This content is not a substitute for medical advice and does not constitute a recommendation to treat, alleviate, or prevent any disease.